Sofinnova Investments, Inc. Galapagos Nv Put Options Transaction History

Sofinnova Investments, Inc.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q2 2019 Aug 13, 2019	SELL	$111.45 - $128.93 $2.23 Million - $2.58 Million	-20,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $1.79 Million - $2.36 Million	20,000 New	20,000 $2.36 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.79B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.